LI-RADS CT/MRI Treatment Response Assessment Update in 2024

LI-RADS CT/MRI Treatment Response Assessment Update in 2024

The liver imaging reporting and data system (LI-RADS) CT/MRI treatment response assessment (TRA) provides a standardized framework for evaluating treatment response following loco-regional therapy for hepatocellular carcinoma (HCC). Initially introduced in 2017, it was revised in 2024 to reflect...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jaeseung Shin, Kyowon Gu, Ji Hye Min
Format:	Article
Language:	English
Published:	The Korean Society of Radiology 2025-05-01
Series:	Journal of the Korean Society of Radiology
Subjects:	liver hepatocellular carcinoma liver imaging reporting and data system treatment response
Online Access:	https://doi.org/10.3348/jksr.2025.0028
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Value of threshold growth for the diagnosis of hepatocellular carcinoma using LI-RADS
by: Jae Seok Bae, et al.
Published: (2025-07-01)

LI-RADS: concordance between energy-integrating computed tomography, photon-counting detector computed tomography and magnetic resonance imaging
by: Lukas Müller, et al.
Published: (2025-08-01)

Association between Radiological Response after Locoregional Treatment and Histopathological Findings in Patients Undergoing Liver Transplant for Hepatocarcinoma
by: Mohamed Hassin Mohamed Chairi, et al.
Published: (2025-01-01)

A special type of liver failure after partial hepatectomy: a case report
by: Linxiao Gao, et al.
Published: (2025-06-01)

Machine learning model based on dynamic contrast-enhanced ultrasound assisting LI-RADS diagnosis of HCC: A multicenter diagnostic study
by: Meiqin Xiao, et al.
Published: (2024-10-01)

Evaluation of the effect of locoregional treatment on metabolic liver function in hepatocellular carcinoma using 18F-FDGal PET/CT
by: Mona Kjærbøl Kristiansen, et al.
Published: (2025-07-01)

Unresectable ectopic hepatocellular carcinoma in the left sub-diaphragmatic area and retroperitoneum treated with TACE: case report and literature review
by: Chao-Bang Xie, et al.
Published: (2025-12-01)

Hepatogastric fistula formation after liver chemoembolization in a patient with hepatocellular carcinoma
by: S. A. Ivanov, et al.
Published: (2023-03-01)

A Comprehensive Overview of In-patients Treated for Hepatocellular Carcinoma at a Tertiary Care Facility in Tanzania
by: Ally Mwanga, et al.
Published: (2023-03-01)

Liver Transplantation in the Treatment of Unresectable Hepatocellular Carcinoma in the Absence of Liver Cirrhosis
by: O. D. Olisov, et al.
Published: (2018-09-01)

Hepatocellular carcinoma in a sheep
by: Zabid Yener, et al.

Assessment of LI-RADS Efficacy in the Classification of Hepatocellular Carcinoma and Benign Liver Nodules Using DCE-MRI Features and ADC MRI
by: Suhail Najm Alareer Hayder, et al.
Published: (2025-07-01)

LI-RADS-based hepatocellular carcinoma risk mapping using contrast-enhanced MRI and self-configuring deep learning
by: Róbert Stollmayer, et al.
Published: (2025-03-01)

FEATURES ARTERIAL ANATOMY OF THE LIVER AND ENDOVASCULAR CHEMOEMBOLIZATION OF THE HEPATIC ARTERY IN THE TREATMENT OF PRIMARY AND METASTATIC LIVER CANCERS
by: V. V. Plechev, et al.
Published: (2017-02-01)

Liquid biopsy in hepatocellular carcinoma: Challenges, advances, and clinical implications
by: Jaeho Park, et al.
Published: (2025-02-01)

Comprehensive review of the vascular niche in regulating liver regeneration, fibrosis, and hepatocellular carcinoma
by: Yutian Chen, et al.
Published: (2025-06-01)

Associations between non-insulin-based insulin resistance surrogate markers and liver-related outcomes in metabolic dysfunction-associated steatotic liver disease: a nationwide cohort study in South Korea
by: Sang Yi Moon, et al.
Published: (2025-04-01)

Retinoic acids and nuclear receptor signaling in liver development: Pathogenic roles in liver diseases
by: Wen Jia, et al.
Published: (2024-03-01)

Prognostic nomogram for recurrence of hepatocellular carcinoma after liver transplantation for decision making on postoperative adjuvant therapy
by: Chen-Hao Gao, et al.
Published: (2025-07-01)

Prediction models after hepatectomy for hepatocellular carcinoma-based ultrasonic radiomics: an observational study
by: Dong Jiang, et al.
Published: (2025-08-01)

Correspondence to editorial 1 on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: insights from the IMbrave150 Trial”
by: Sung Hwan Lee, et al.
Published: (2025-01-01)

Correspondence to letter to the editor on “Genomic biomarkers to predict response to atezolizumab plus bevacizumab immunotherapy in hepatocellular carcinoma: Insights from the IMbrave150 trial”
by: Sung Hwan Lee, et al.
Published: (2025-01-01)

Uncooled TATO microwave system for liver ablation
by: Eduardo Crespo, et al.
Published: (2022-12-01)

The role of early MRI in assessing the risk of local tumor progression following irreversible electroporation for hepatocellular carcinoma treatment
by: Lorenzo Carlo Pescatori, et al.
Published: (2025-12-01)

DynTransNet: Dynamic Transformer Network with multi-scale attention for liver cancer segmentation
by: Siming Zheng, et al.
Published: (2025-06-01)

Correspondence to letter to the editor on “Non-linear association between liver fibrosis scores and viral load in patients with chronic hepatitis B”
by: Gi-Ae Kim, et al.
Published: (2025-01-01)

Durable complete response after discontinuation of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma with portal vein tumor thrombosis: the first report
by: Pramod Kumar, et al.
Published: (2025-03-01)

Lipoprotein(a) as a potential marker of residual liver function in hepatocellular carcinoma
by: Mario Uccello, et al.
Published: (2011-01-01)

The incidence of malignant tumors in patients with liver cirrhosis and the impact of the development of hepatocellular carcinoma on the overall survival of patients with cirrhosis
by: Vladislav V. Petkau, et al.
Published: (2024-03-01)

Agenesis of the left hepatic lobe undergoing laparoscopic hepatectomy for hepatocellular carcinoma: a case report
by: Katsunori Matsushita, et al.
Published: (2017-03-01)

Application of Robotic Surgery in Hepatocellular Carcinoma
by: Li PH, et al.
Published: (2025-06-01)

Multicenter, prospective clinical trial for balloon-occluded alternative infusion of cisplatin solution and fragmented gelatin particles of transarterial chemoembolization for hepatocellular carcinoma beyond up-to-seven criteria
by: Sodai Hoshiai, et al.
Published: (2025-05-01)

Criteria and prognostic models for patients with hepatocellular carcinoma undergoing liver transplantation
by: Meng Sha, et al.
Published: (2025-02-01)

Role of cytokines in hepatocellular carcinoma
by: T. Aghayev, et al.
Published: (2022-11-01)

Morphological and Functional Changes in Hepatic System Precipitate Liver Disease in Elderly: Addressing Knowledge Gaps and Treatment Challenges
by: Fatrian Dwicahya, et al.
Published: (2024-12-01)

Efficacy and safety of laparoscopic hepatectomy for hepatocellular carcinoma comorbid with cirrhosis
by: Yoshihiro Inoue, et al.
Published: (2020-09-01)

Diagnostic Accuracy of Sonazoid-Enhanced Ultrasonography for Detection of Liver Metastasis
by: Anas Elgenidy, et al.
Published: (2025-04-01)

Unusual Presentation of Hepatocellular Carcinoma with Peritoneal Carcinomatosis: Importance of Abdominal Distension as a Clinical Indicator
by: Mariam Shahid, et al.
Published: (2023-07-01)

A case of resected hepatocellular carcinoma with gallbladder metastasis
by: Takaaki Hanazawa, et al.
Published: (2021-06-01)

Correspondence to letter to the editor 1 on “Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma: A nationwide cohort study”
by: Seogsong Jeong, et al.
Published: (2025-04-01)